April 12, 2025
We are proud to announce that our U.S. patent US 12,268,712B2 has officially been granted. This milestone recognizes our innovation and dedication in the field... Read More
UPCOMING EVENTS
CPHI Frankfurt, October 28-30, 2025, Frankfurt, Germany
We are excited to exhibit this year’s CPHI, one of the world’s largest pharma event, taking place on October 28-30, 2025 in Frankfurt, Germany
You can meet us and discover our innovative product portfolio in Hall 4.0 at our Booth 4S144.
BIO International Convention
June 16-19, 2025 Boston, USA
We are excited to be visiting BIO 2025, the world’s largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with more than 18,500 industry leaders from across the globe.
RECENT NEWS
-
-
March 20, 2025
Our abstract entitled “Improving Vaginal Health With a Zinc-Containing Vaginal Hydrogel: A Prospective Cohort Study” has been selected as a Moderated E-Poster/Scientific Salon Presentation at... Read More -
March 19, 2025
In a paper, published in Gels (an MDPI journal), we have showed JUVIAGEL’s role as an effective, nonhormonal, drug-free, and local adjunct treatment for a... Read More -
December 13, 2024
In a paper, published in Gels (an MDPI journal), we have assessed the bioavailability of an estriol-containing vaginal hydrogel. The results suggest the potential of... Read More -
December 7, 2023
In a paper, published in Science Translational Medicine, we have showed that JUVIAGEL could be effective against recurrent yeast infections. More in our Press Release. -
-
July 17, 2023
Fempharma has been successfully audited for ISO 13485:2016 Manufacturing and Trade of Medical Devices by Tequa-Zert, a TÜV Hessen partner. -
June 25th, 2023
We have presented our latest study “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle... Read More
